nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Naltrexone—alcohol dependence	0.595	1	CbGbCtD
Raltegravir—CCR1—Peptide GPCRs—OPRK1—alcohol dependence	0.0077	0.0594	CbGpPWpGaD
Raltegravir—CCR1—cardiovascular system—alcohol dependence	0.0056	0.131	CbGeAlD
Raltegravir—CCR1—Peptide GPCRs—OPRD1—alcohol dependence	0.00518	0.0399	CbGpPWpGaD
Raltegravir—CCR1—digestive system—alcohol dependence	0.00465	0.108	CbGeAlD
Raltegravir—CCR1—blood—alcohol dependence	0.00443	0.103	CbGeAlD
Raltegravir—CCR1—midbrain—alcohol dependence	0.00438	0.102	CbGeAlD
Raltegravir—CCR1—Peptide GPCRs—OPRM1—alcohol dependence	0.00398	0.0307	CbGpPWpGaD
Raltegravir—CCR1—endocrine gland—alcohol dependence	0.00384	0.0896	CbGeAlD
Raltegravir—CCR1—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00362	0.0279	CbGpPWpGaD
Raltegravir—CCR1—nervous system—alcohol dependence	0.0036	0.0838	CbGeAlD
Raltegravir—CCR1—liver—alcohol dependence	0.00347	0.0807	CbGeAlD
Raltegravir—CCR1—central nervous system—alcohol dependence	0.00346	0.0807	CbGeAlD
Raltegravir—CCR1—G alpha (i) signalling events—OPRK1—alcohol dependence	0.00306	0.0236	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00288	0.0222	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00284	0.0219	CbGpPWpGaD
Raltegravir—CCR1—brain—alcohol dependence	0.00275	0.0641	CbGeAlD
Raltegravir—CCR1—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.00243	0.0188	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00243	0.0187	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.00233	0.018	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—OPRD1—alcohol dependence	0.00205	0.0158	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—PDYN—alcohol dependence	0.00197	0.0152	CbGpPWpGaD
Raltegravir—UGT1A1—digestive system—alcohol dependence	0.00191	0.0446	CbGeAlD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00191	0.0147	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00187	0.0144	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—OPRK1—alcohol dependence	0.00185	0.0143	CbGpPWpGaD
Raltegravir—UGT1A1—blood—alcohol dependence	0.00182	0.0424	CbGeAlD
Raltegravir—CCR1—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00172	0.0133	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CHRM2—alcohol dependence	0.00172	0.0133	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00163	0.0126	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.0016	0.0123	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—OPRM1—alcohol dependence	0.00158	0.0122	CbGpPWpGaD
Raltegravir—UGT1A1—endocrine gland—alcohol dependence	0.00158	0.0368	CbGeAlD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00157	0.0121	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00147	0.0113	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—NPY—alcohol dependence	0.00145	0.0112	CbGpPWpGaD
Raltegravir—UGT1A1—liver—alcohol dependence	0.00142	0.0332	CbGeAlD
Raltegravir—CCR1—G alpha (i) signalling events—HTR1B—alcohol dependence	0.0014	0.0108	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00137	0.0106	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.0013	0.01	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00126	0.00969	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—OPRD1—alcohol dependence	0.00124	0.00959	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—DRD4—alcohol dependence	0.00123	0.00946	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—PDYN—alcohol dependence	0.00119	0.00919	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CNR1—alcohol dependence	0.00117	0.00903	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00116	0.00891	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—ALDH3A1—alcohol dependence	0.00114	0.00882	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—DRD2—alcohol dependence	0.00114	0.00881	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00114	0.00879	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00114	0.00877	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00112	0.0086	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CRHR1—alcohol dependence	0.00111	0.00855	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00109	0.00838	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ADH6—alcohol dependence	0.00108	0.00832	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00106	0.00817	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00106	0.00817	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GGT2—alcohol dependence	0.00106	0.00817	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OPRK1—alcohol dependence	0.00105	0.00806	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CHRM2—alcohol dependence	0.00104	0.00803	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000975	0.00752	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—OPRM1—alcohol dependence	0.000957	0.00738	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OPRK1—alcohol dependence	0.00095	0.00732	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000931	0.00718	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000908	0.007	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000908	0.007	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ADH1A—alcohol dependence	0.000894	0.00689	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—NPY—alcohol dependence	0.000881	0.00679	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CRH—alcohol dependence	0.00085	0.00655	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—HTR1B—alcohol dependence	0.00085	0.00655	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000765	0.00589	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ADH4—alcohol dependence	0.00076	0.00586	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000758	0.00584	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000743	0.00573	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—DRD4—alcohol dependence	0.000743	0.00572	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—ADH7—alcohol dependence	0.000737	0.00568	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CNR1—alcohol dependence	0.000709	0.00547	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GGT2—alcohol dependence	0.000707	0.00545	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000703	0.00542	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—HTR7—alcohol dependence	0.000692	0.00533	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—DRD2—alcohol dependence	0.000692	0.00533	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PDYN—alcohol dependence	0.000674	0.00519	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ADH7—alcohol dependence	0.000646	0.00498	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—alcohol dependence	0.000639	0.00493	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OPRD1—alcohol dependence	0.000638	0.00492	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000636	0.00491	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CRHR1—alcohol dependence	0.000626	0.00483	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GGT2—alcohol dependence	0.00062	0.00478	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PDYN—alcohol dependence	0.000612	0.00472	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000589	0.00454	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AVP—alcohol dependence	0.000582	0.00449	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CRHR1—alcohol dependence	0.000569	0.00439	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ADH1B—alcohol dependence	0.000567	0.00437	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—OPRK1—alcohol dependence	0.000561	0.00432	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000541	0.00417	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CHRM2—alcohol dependence	0.000535	0.00412	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000508	0.00392	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GGT1—alcohol dependence	0.000501	0.00386	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—NPY—alcohol dependence	0.000498	0.00384	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—OPRM1—alcohol dependence	0.000491	0.00379	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—HTR2A—alcohol dependence	0.000485	0.00374	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR1B—alcohol dependence	0.00048	0.0037	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CRH—alcohol dependence	0.00048	0.0037	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—MAOB—alcohol dependence	0.00047	0.00362	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—NPY—alcohol dependence	0.000452	0.00348	CbGpPWpGaD
Raltegravir—Infestation NOS—Naltrexone—alcohol dependence	0.00044	0.0019	CcSEcCtD
Raltegravir—Infestation—Naltrexone—alcohol dependence	0.00044	0.0019	CcSEcCtD
Raltegravir—Depression—Naltrexone—alcohol dependence	0.000439	0.00189	CcSEcCtD
Raltegravir—Epistaxis—Acamprosate—alcohol dependence	0.000439	0.00189	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CRH—alcohol dependence	0.000436	0.00336	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HTR1B—alcohol dependence	0.000436	0.00336	CbGpPWpGaD
Raltegravir—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000434	0.00187	CcSEcCtD
Raltegravir—Mental disability—Citalopram—alcohol dependence	0.000432	0.00187	CcSEcCtD
Raltegravir—Asthenia—Disulfiram—alcohol dependence	0.000432	0.00186	CcSEcCtD
Raltegravir—Myocardial infarction—Naltrexone—alcohol dependence	0.000431	0.00186	CcSEcCtD
Raltegravir—Lymphadenopathy—Citalopram—alcohol dependence	0.000424	0.00183	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—DRD4—alcohol dependence	0.00042	0.00324	CbGpPWpGaD
Raltegravir—Sleep disorder—Citalopram—alcohol dependence	0.000418	0.0018	CcSEcCtD
Raltegravir—Hepatitis—Acamprosate—alcohol dependence	0.000417	0.0018	CcSEcCtD
Raltegravir—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000416	0.0018	CcSEcCtD
Raltegravir—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.000416	0.00179	CcSEcCtD
Raltegravir—Diabetes mellitus—Citalopram—alcohol dependence	0.000416	0.00179	CcSEcCtD
Raltegravir—Hypoaesthesia—Acamprosate—alcohol dependence	0.000415	0.00179	CcSEcCtD
Raltegravir—Hallucination—Acamprosate—alcohol dependence	0.000415	0.00179	CcSEcCtD
Raltegravir—Epistaxis—Naltrexone—alcohol dependence	0.000415	0.00179	CcSEcCtD
Raltegravir—Oedema peripheral—Acamprosate—alcohol dependence	0.000411	0.00177	CcSEcCtD
Raltegravir—Gastroenteritis—Citalopram—alcohol dependence	0.000408	0.00176	CcSEcCtD
Raltegravir—Hepatic failure—Citalopram—alcohol dependence	0.000402	0.00174	CcSEcCtD
Raltegravir—Visual impairment—Acamprosate—alcohol dependence	0.000402	0.00174	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CNR1—alcohol dependence	0.000401	0.00309	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—ALDH2—alcohol dependence	0.000399	0.00308	CbGpPWpGaD
Raltegravir—Dizziness—Disulfiram—alcohol dependence	0.000398	0.00172	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—SLC6A4—alcohol dependence	0.000398	0.00307	CbGpPWpGaD
Raltegravir—Nasal congestion—Citalopram—alcohol dependence	0.000397	0.00171	CcSEcCtD
Raltegravir—Hepatitis—Naltrexone—alcohol dependence	0.000395	0.0017	CcSEcCtD
Raltegravir—Hallucination—Naltrexone—alcohol dependence	0.000393	0.0017	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—HTR7—alcohol dependence	0.000391	0.00301	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—DRD2—alcohol dependence	0.000391	0.00301	CbGpPWpGaD
Raltegravir—Tinnitus—Acamprosate—alcohol dependence	0.000389	0.00168	CcSEcCtD
Raltegravir—Connective tissue disorder—Naltrexone—alcohol dependence	0.000388	0.00167	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—POMC—alcohol dependence	0.000387	0.00298	CbGpPWpGaD
Raltegravir—Hot flush—Citalopram—alcohol dependence	0.000387	0.00167	CcSEcCtD
Raltegravir—Amnesia—Citalopram—alcohol dependence	0.000385	0.00166	CcSEcCtD
Raltegravir—Increased appetite—Citalopram—alcohol dependence	0.000385	0.00166	CcSEcCtD
Raltegravir—Menopausal symptoms—Citalopram—alcohol dependence	0.000383	0.00165	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—DRD4—alcohol dependence	0.000381	0.00294	CbGpPWpGaD
Raltegravir—Rash—Disulfiram—alcohol dependence	0.00038	0.00164	CcSEcCtD
Raltegravir—Headache—Disulfiram—alcohol dependence	0.000377	0.00163	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—OPRD1—alcohol dependence	0.000377	0.00291	CbGpPWpGaD
Raltegravir—Immune system disorder—Acamprosate—alcohol dependence	0.000377	0.00163	CcSEcCtD
Raltegravir—Chills—Acamprosate—alcohol dependence	0.000374	0.00162	CcSEcCtD
Raltegravir—Arthritis—Citalopram—alcohol dependence	0.000372	0.00161	CcSEcCtD
Raltegravir—Lethargy—Citalopram—alcohol dependence	0.000369	0.00159	CcSEcCtD
Raltegravir—Eye disorder—Naltrexone—alcohol dependence	0.000369	0.00159	CcSEcCtD
Raltegravir—Alopecia—Acamprosate—alcohol dependence	0.000369	0.00159	CcSEcCtD
Raltegravir—Tinnitus—Naltrexone—alcohol dependence	0.000368	0.00159	CcSEcCtD
Raltegravir—Cardiac disorder—Naltrexone—alcohol dependence	0.000366	0.00158	CcSEcCtD
Raltegravir—Mental disorder—Acamprosate—alcohol dependence	0.000366	0.00158	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CNR1—alcohol dependence	0.000364	0.00281	CbGpPWpGaD
Raltegravir—Malnutrition—Acamprosate—alcohol dependence	0.000363	0.00157	CcSEcCtD
Raltegravir—Pain in extremity—Citalopram—alcohol dependence	0.000362	0.00156	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PDYN—alcohol dependence	0.000361	0.00279	CbGpPWpGaD
Raltegravir—Angiopathy—Naltrexone—alcohol dependence	0.000358	0.00155	CcSEcCtD
Raltegravir—Flatulence—Acamprosate—alcohol dependence	0.000358	0.00155	CcSEcCtD
Raltegravir—Immune system disorder—Naltrexone—alcohol dependence	0.000357	0.00154	CcSEcCtD
Raltegravir—Affect lability—Citalopram—alcohol dependence	0.000356	0.00154	CcSEcCtD
Raltegravir—Migraine—Citalopram—alcohol dependence	0.000356	0.00154	CcSEcCtD
Raltegravir—Mediastinal disorder—Naltrexone—alcohol dependence	0.000356	0.00154	CcSEcCtD
Raltegravir—Dysgeusia—Acamprosate—alcohol dependence	0.000356	0.00154	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—HTR7—alcohol dependence	0.000355	0.00274	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—DRD2—alcohol dependence	0.000355	0.00274	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC6A3—alcohol dependence	0.000355	0.00273	CbGpPWpGaD
Raltegravir—Chills—Naltrexone—alcohol dependence	0.000354	0.00153	CcSEcCtD
Raltegravir—Psychotic disorder—Citalopram—alcohol dependence	0.000353	0.00152	CcSEcCtD
Raltegravir—Nervousness—Acamprosate—alcohol dependence	0.000353	0.00152	CcSEcCtD
Raltegravir—Back pain—Acamprosate—alcohol dependence	0.000351	0.00152	CcSEcCtD
Raltegravir—Face oedema—Citalopram—alcohol dependence	0.000349	0.00151	CcSEcCtD
Raltegravir—Alopecia—Naltrexone—alcohol dependence	0.000349	0.00151	CcSEcCtD
Raltegravir—Mental disorder—Naltrexone—alcohol dependence	0.000346	0.00149	CcSEcCtD
Raltegravir—Malnutrition—Naltrexone—alcohol dependence	0.000344	0.00148	CcSEcCtD
Raltegravir—Mood swings—Citalopram—alcohol dependence	0.000343	0.00148	CcSEcCtD
Raltegravir—Tremor—Acamprosate—alcohol dependence	0.00034	0.00147	CcSEcCtD
Raltegravir—Flatulence—Naltrexone—alcohol dependence	0.000339	0.00146	CcSEcCtD
Raltegravir—Ill-defined disorder—Acamprosate—alcohol dependence	0.000337	0.00145	CcSEcCtD
Raltegravir—Dysgeusia—Naltrexone—alcohol dependence	0.000337	0.00145	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CRHR1—alcohol dependence	0.000336	0.00259	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—WASF2—alcohol dependence	0.000336	0.00259	CbGpPWpGaD
Raltegravir—Anaemia—Acamprosate—alcohol dependence	0.000336	0.00145	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—GGT1—alcohol dependence	0.000334	0.00258	CbGpPWpGaD
Raltegravir—Agitation—Acamprosate—alcohol dependence	0.000334	0.00144	CcSEcCtD
Raltegravir—Nervousness—Naltrexone—alcohol dependence	0.000334	0.00144	CcSEcCtD
Raltegravir—Back pain—Naltrexone—alcohol dependence	0.000333	0.00144	CcSEcCtD
Raltegravir—Dry skin—Citalopram—alcohol dependence	0.000332	0.00143	CcSEcCtD
Raltegravir—Abdominal pain upper—Citalopram—alcohol dependence	0.00033	0.00143	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—AVP—alcohol dependence	0.000329	0.00254	CbGpPWpGaD
Raltegravir—Malaise—Acamprosate—alcohol dependence	0.000328	0.00141	CcSEcCtD
Raltegravir—Breast disorder—Citalopram—alcohol dependence	0.000327	0.00141	CcSEcCtD
Raltegravir—Vertigo—Acamprosate—alcohol dependence	0.000326	0.00141	CcSEcCtD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000326	0.00251	CbGpPWpGaD
Raltegravir—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000326	0.00141	CcSEcCtD
Raltegravir—Nasopharyngitis—Citalopram—alcohol dependence	0.000323	0.0014	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—WASF1—alcohol dependence	0.000322	0.00248	CbGpPWpGaD
Raltegravir—Tremor—Naltrexone—alcohol dependence	0.000322	0.00139	CcSEcCtD
Raltegravir—Palpitations—Acamprosate—alcohol dependence	0.000321	0.00139	CcSEcCtD
Raltegravir—Gastritis—Citalopram—alcohol dependence	0.00032	0.00138	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—CYP2E1—alcohol dependence	0.000319	0.00246	CbGpPWpGaD
Raltegravir—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000319	0.00138	CcSEcCtD
Raltegravir—Ill-defined disorder—Naltrexone—alcohol dependence	0.000319	0.00138	CcSEcCtD
Raltegravir—Cough—Acamprosate—alcohol dependence	0.000317	0.00137	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CHRM2—alcohol dependence	0.000316	0.00244	CbGpPWpGaD
Raltegravir—Agitation—Naltrexone—alcohol dependence	0.000316	0.00136	CcSEcCtD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000315	0.00243	CbGpPWpGaD
Raltegravir—Abdominal distension—Citalopram—alcohol dependence	0.000315	0.00136	CcSEcCtD
Raltegravir—Hypertension—Acamprosate—alcohol dependence	0.000314	0.00135	CcSEcCtD
Raltegravir—Influenza—Citalopram—alcohol dependence	0.000313	0.00135	CcSEcCtD
Raltegravir—Malaise—Naltrexone—alcohol dependence	0.00031	0.00134	CcSEcCtD
Raltegravir—Eosinophilia—Citalopram—alcohol dependence	0.00031	0.00134	CcSEcCtD
Raltegravir—Myalgia—Acamprosate—alcohol dependence	0.000309	0.00134	CcSEcCtD
Raltegravir—Chest pain—Acamprosate—alcohol dependence	0.000309	0.00134	CcSEcCtD
Raltegravir—Arthralgia—Acamprosate—alcohol dependence	0.000309	0.00134	CcSEcCtD
Raltegravir—Anxiety—Acamprosate—alcohol dependence	0.000308	0.00133	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000307	0.00133	CcSEcCtD
Raltegravir—Discomfort—Acamprosate—alcohol dependence	0.000306	0.00132	CcSEcCtD
Raltegravir—Palpitations—Naltrexone—alcohol dependence	0.000304	0.00131	CcSEcCtD
Raltegravir—Dry mouth—Acamprosate—alcohol dependence	0.000303	0.00131	CcSEcCtD
Raltegravir—Bronchitis—Citalopram—alcohol dependence	0.000301	0.0013	CcSEcCtD
Raltegravir—Cough—Naltrexone—alcohol dependence	0.0003	0.00129	CcSEcCtD
Raltegravir—Abdominal discomfort—Citalopram—alcohol dependence	0.0003	0.00129	CcSEcCtD
Raltegravir—Confusional state—Acamprosate—alcohol dependence	0.000299	0.00129	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—AVP—alcohol dependence	0.000299	0.0023	CbGpPWpGaD
Raltegravir—Hypertension—Naltrexone—alcohol dependence	0.000297	0.00128	CcSEcCtD
Raltegravir—Infection—Acamprosate—alcohol dependence	0.000295	0.00127	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—GGT1—alcohol dependence	0.000293	0.00226	CbGpPWpGaD
Raltegravir—Arthralgia—Naltrexone—alcohol dependence	0.000293	0.00126	CcSEcCtD
Raltegravir—Myalgia—Naltrexone—alcohol dependence	0.000293	0.00126	CcSEcCtD
Raltegravir—Chest pain—Naltrexone—alcohol dependence	0.000293	0.00126	CcSEcCtD
Raltegravir—Anxiety—Naltrexone—alcohol dependence	0.000292	0.00126	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000291	0.00125	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000291	0.00125	CcSEcCtD
Raltegravir—Thrombocytopenia—Acamprosate—alcohol dependence	0.00029	0.00125	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—OPRM1—alcohol dependence	0.00029	0.00224	CbGpPWpGaD
Raltegravir—Discomfort—Naltrexone—alcohol dependence	0.000289	0.00125	CcSEcCtD
Raltegravir—Skin disorder—Acamprosate—alcohol dependence	0.000288	0.00124	CcSEcCtD
Raltegravir—Erectile dysfunction—Citalopram—alcohol dependence	0.000288	0.00124	CcSEcCtD
Raltegravir—Hyperhidrosis—Acamprosate—alcohol dependence	0.000287	0.00124	CcSEcCtD
Raltegravir—Dry mouth—Naltrexone—alcohol dependence	0.000286	0.00124	CcSEcCtD
Raltegravir—Weight increased—Citalopram—alcohol dependence	0.000284	0.00123	CcSEcCtD
Raltegravir—Confusional state—Naltrexone—alcohol dependence	0.000283	0.00122	CcSEcCtD
Raltegravir—Weight decreased—Citalopram—alcohol dependence	0.000283	0.00122	CcSEcCtD
Raltegravir—Hyperglycaemia—Citalopram—alcohol dependence	0.000282	0.00122	CcSEcCtD
Raltegravir—Infection—Naltrexone—alcohol dependence	0.000279	0.0012	CcSEcCtD
Raltegravir—Infestation—Citalopram—alcohol dependence	0.000279	0.0012	CcSEcCtD
Raltegravir—Infestation NOS—Citalopram—alcohol dependence	0.000279	0.0012	CcSEcCtD
Raltegravir—Depression—Citalopram—alcohol dependence	0.000278	0.0012	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000276	0.00119	CcSEcCtD
Raltegravir—Nervous system disorder—Naltrexone—alcohol dependence	0.000275	0.00119	CcSEcCtD
Raltegravir—Acute coronary syndrome—Citalopram—alcohol dependence	0.000275	0.00119	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000274	0.00211	CbGpPWpGaD
Raltegravir—Myocardial infarction—Citalopram—alcohol dependence	0.000273	0.00118	CcSEcCtD
Raltegravir—Neuropathy peripheral—Citalopram—alcohol dependence	0.000273	0.00118	CcSEcCtD
Raltegravir—Skin disorder—Naltrexone—alcohol dependence	0.000273	0.00118	CcSEcCtD
Raltegravir—Hyperhidrosis—Naltrexone—alcohol dependence	0.000271	0.00117	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00027	0.00117	CcSEcCtD
Raltegravir—Insomnia—Acamprosate—alcohol dependence	0.000268	0.00116	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NPY—alcohol dependence	0.000267	0.00206	CbGpPWpGaD
Raltegravir—Paraesthesia—Acamprosate—alcohol dependence	0.000266	0.00115	CcSEcCtD
Raltegravir—Haematuria—Citalopram—alcohol dependence	0.000266	0.00115	CcSEcCtD
Raltegravir—Somnolence—Acamprosate—alcohol dependence	0.000264	0.00114	CcSEcCtD
Raltegravir—Hepatobiliary disease—Citalopram—alcohol dependence	0.000264	0.00114	CcSEcCtD
Raltegravir—Epistaxis—Citalopram—alcohol dependence	0.000263	0.00113	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—MAOA—alcohol dependence	0.000263	0.00202	CbGpPWpGaD
Raltegravir—Dyspepsia—Acamprosate—alcohol dependence	0.000261	0.00113	CcSEcCtD
Raltegravir—Decreased appetite—Acamprosate—alcohol dependence	0.000258	0.00111	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR1B—alcohol dependence	0.000258	0.00199	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CRH—alcohol dependence	0.000258	0.00199	CbGpPWpGaD
Raltegravir—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000256	0.0011	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000256	0.0011	CcSEcCtD
Raltegravir—Insomnia—Naltrexone—alcohol dependence	0.000254	0.0011	CcSEcCtD
Raltegravir—Constipation—Acamprosate—alcohol dependence	0.000254	0.00109	CcSEcCtD
Raltegravir—Pain—Acamprosate—alcohol dependence	0.000254	0.00109	CcSEcCtD
Raltegravir—Paraesthesia—Naltrexone—alcohol dependence	0.000252	0.00109	CcSEcCtD
Raltegravir—Hepatitis—Citalopram—alcohol dependence	0.00025	0.00108	CcSEcCtD
Raltegravir—Somnolence—Naltrexone—alcohol dependence	0.000249	0.00108	CcSEcCtD
Raltegravir—Hallucination—Citalopram—alcohol dependence	0.000249	0.00107	CcSEcCtD
Raltegravir—Hypoaesthesia—Citalopram—alcohol dependence	0.000249	0.00107	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—HTR2A—alcohol dependence	0.000249	0.00192	CbGpPWpGaD
Raltegravir—Urinary tract disorder—Citalopram—alcohol dependence	0.000247	0.00107	CcSEcCtD
Raltegravir—Oedema peripheral—Citalopram—alcohol dependence	0.000246	0.00106	CcSEcCtD
Raltegravir—Connective tissue disorder—Citalopram—alcohol dependence	0.000246	0.00106	CcSEcCtD
Raltegravir—Urethral disorder—Citalopram—alcohol dependence	0.000245	0.00106	CcSEcCtD
Raltegravir—Feeling abnormal—Acamprosate—alcohol dependence	0.000244	0.00105	CcSEcCtD
Raltegravir—Decreased appetite—Naltrexone—alcohol dependence	0.000244	0.00105	CcSEcCtD
Raltegravir—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000242	0.00105	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000242	0.00105	CcSEcCtD
Raltegravir—Fatigue—Naltrexone—alcohol dependence	0.000242	0.00104	CcSEcCtD
Raltegravir—Visual impairment—Citalopram—alcohol dependence	0.000241	0.00104	CcSEcCtD
Raltegravir—Pain—Naltrexone—alcohol dependence	0.00024	0.00104	CcSEcCtD
Raltegravir—Constipation—Naltrexone—alcohol dependence	0.00024	0.00104	CcSEcCtD
Raltegravir—Erythema multiforme—Citalopram—alcohol dependence	0.000237	0.00102	CcSEcCtD
Raltegravir—Urticaria—Acamprosate—alcohol dependence	0.000236	0.00102	CcSEcCtD
Raltegravir—Abdominal pain—Acamprosate—alcohol dependence	0.000234	0.00101	CcSEcCtD
Raltegravir—Body temperature increased—Acamprosate—alcohol dependence	0.000234	0.00101	CcSEcCtD
Raltegravir—Eye disorder—Citalopram—alcohol dependence	0.000234	0.00101	CcSEcCtD
Raltegravir—Tinnitus—Citalopram—alcohol dependence	0.000233	0.00101	CcSEcCtD
Raltegravir—Cardiac disorder—Citalopram—alcohol dependence	0.000232	0.001	CcSEcCtD
Raltegravir—Feeling abnormal—Naltrexone—alcohol dependence	0.000231	0.000998	CcSEcCtD
Raltegravir—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000229	0.00099	CcSEcCtD
Raltegravir—Angiopathy—Citalopram—alcohol dependence	0.000227	0.00098	CcSEcCtD
Raltegravir—Immune system disorder—Citalopram—alcohol dependence	0.000226	0.000975	CcSEcCtD
Raltegravir—Mediastinal disorder—Citalopram—alcohol dependence	0.000225	0.000973	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—DRD4—alcohol dependence	0.000225	0.00174	CbGpPWpGaD
Raltegravir—Chills—Citalopram—alcohol dependence	0.000225	0.000969	CcSEcCtD
Raltegravir—Urticaria—Naltrexone—alcohol dependence	0.000223	0.000962	CcSEcCtD
Raltegravir—Abdominal pain—Naltrexone—alcohol dependence	0.000222	0.000957	CcSEcCtD
Raltegravir—Body temperature increased—Naltrexone—alcohol dependence	0.000222	0.000957	CcSEcCtD
Raltegravir—Alopecia—Citalopram—alcohol dependence	0.000221	0.000954	CcSEcCtD
Raltegravir—Mental disorder—Citalopram—alcohol dependence	0.000219	0.000946	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—POMC—alcohol dependence	0.000219	0.00169	CbGpPWpGaD
Raltegravir—Hypersensitivity—Acamprosate—alcohol dependence	0.000218	0.000943	CcSEcCtD
Raltegravir—Malnutrition—Citalopram—alcohol dependence	0.000218	0.00094	CcSEcCtD
Raltegravir—Erythema—Citalopram—alcohol dependence	0.000218	0.00094	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CNR1—alcohol dependence	0.000215	0.00166	CbGpPWpGaD
Raltegravir—Flatulence—Citalopram—alcohol dependence	0.000215	0.000926	CcSEcCtD
Raltegravir—Dysgeusia—Citalopram—alcohol dependence	0.000213	0.000921	CcSEcCtD
Raltegravir—Asthenia—Acamprosate—alcohol dependence	0.000213	0.000918	CcSEcCtD
Raltegravir—Nervousness—Citalopram—alcohol dependence	0.000212	0.000913	CcSEcCtD
Raltegravir—Back pain—Citalopram—alcohol dependence	0.000211	0.000909	CcSEcCtD
Raltegravir—Pruritus—Acamprosate—alcohol dependence	0.00021	0.000905	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—DRD2—alcohol dependence	0.00021	0.00162	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR7—alcohol dependence	0.00021	0.00162	CbGpPWpGaD
Raltegravir—Hypersensitivity—Naltrexone—alcohol dependence	0.000207	0.000892	CcSEcCtD
Raltegravir—Tremor—Citalopram—alcohol dependence	0.000204	0.000881	CcSEcCtD
Raltegravir—Diarrhoea—Acamprosate—alcohol dependence	0.000203	0.000876	CcSEcCtD
Raltegravir—Ill-defined disorder—Citalopram—alcohol dependence	0.000202	0.000872	CcSEcCtD
Raltegravir—Anaemia—Citalopram—alcohol dependence	0.000201	0.000869	CcSEcCtD
Raltegravir—Asthenia—Naltrexone—alcohol dependence	0.000201	0.000869	CcSEcCtD
Raltegravir—Agitation—Citalopram—alcohol dependence	0.0002	0.000864	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—POMC—alcohol dependence	0.000199	0.00153	CbGpPWpGaD
Raltegravir—Pruritus—Naltrexone—alcohol dependence	0.000198	0.000857	CcSEcCtD
Raltegravir—Malaise—Citalopram—alcohol dependence	0.000196	0.000848	CcSEcCtD
Raltegravir—Dizziness—Acamprosate—alcohol dependence	0.000196	0.000846	CcSEcCtD
Raltegravir—Vertigo—Citalopram—alcohol dependence	0.000196	0.000845	CcSEcCtD
Raltegravir—Palpitations—Citalopram—alcohol dependence	0.000192	0.000831	CcSEcCtD
Raltegravir—Diarrhoea—Naltrexone—alcohol dependence	0.000192	0.000828	CcSEcCtD
Raltegravir—Cough—Citalopram—alcohol dependence	0.00019	0.00082	CcSEcCtD
Raltegravir—Vomiting—Acamprosate—alcohol dependence	0.000189	0.000814	CcSEcCtD
Raltegravir—Hypertension—Citalopram—alcohol dependence	0.000188	0.000812	CcSEcCtD
Raltegravir—Rash—Acamprosate—alcohol dependence	0.000187	0.000807	CcSEcCtD
Raltegravir—Dermatitis—Acamprosate—alcohol dependence	0.000187	0.000806	CcSEcCtD
Raltegravir—Headache—Acamprosate—alcohol dependence	0.000186	0.000802	CcSEcCtD
Raltegravir—Dizziness—Naltrexone—alcohol dependence	0.000186	0.000801	CcSEcCtD
Raltegravir—Chest pain—Citalopram—alcohol dependence	0.000185	0.0008	CcSEcCtD
Raltegravir—Arthralgia—Citalopram—alcohol dependence	0.000185	0.0008	CcSEcCtD
Raltegravir—Myalgia—Citalopram—alcohol dependence	0.000185	0.0008	CcSEcCtD
Raltegravir—Anxiety—Citalopram—alcohol dependence	0.000185	0.000798	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADH6—alcohol dependence	0.000185	0.00142	CbGpPWpGaD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000184	0.000795	CcSEcCtD
Raltegravir—Discomfort—Citalopram—alcohol dependence	0.000183	0.000791	CcSEcCtD
Raltegravir—Dry mouth—Citalopram—alcohol dependence	0.000181	0.000783	CcSEcCtD
Raltegravir—Confusional state—Citalopram—alcohol dependence	0.000179	0.000774	CcSEcCtD
Raltegravir—Vomiting—Naltrexone—alcohol dependence	0.000178	0.00077	CcSEcCtD
Raltegravir—Rash—Naltrexone—alcohol dependence	0.000177	0.000763	CcSEcCtD
Raltegravir—Dermatitis—Naltrexone—alcohol dependence	0.000177	0.000763	CcSEcCtD
Raltegravir—Infection—Citalopram—alcohol dependence	0.000177	0.000762	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—AVP—alcohol dependence	0.000177	0.00136	CbGpPWpGaD
Raltegravir—Nausea—Acamprosate—alcohol dependence	0.000176	0.00076	CcSEcCtD
Raltegravir—Headache—Naltrexone—alcohol dependence	0.000176	0.000759	CcSEcCtD
Raltegravir—Nervous system disorder—Citalopram—alcohol dependence	0.000174	0.000752	CcSEcCtD
Raltegravir—Thrombocytopenia—Citalopram—alcohol dependence	0.000174	0.000751	CcSEcCtD
Raltegravir—Skin disorder—Citalopram—alcohol dependence	0.000173	0.000745	CcSEcCtD
Raltegravir—Hyperhidrosis—Citalopram—alcohol dependence	0.000172	0.000742	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—POMC—alcohol dependence	0.000171	0.00132	CbGpPWpGaD
Raltegravir—Nausea—Naltrexone—alcohol dependence	0.000167	0.000719	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000162	0.000699	CcSEcCtD
Raltegravir—Insomnia—Citalopram—alcohol dependence	0.000161	0.000694	CcSEcCtD
Raltegravir—Paraesthesia—Citalopram—alcohol dependence	0.00016	0.000689	CcSEcCtD
Raltegravir—Somnolence—Citalopram—alcohol dependence	0.000158	0.000682	CcSEcCtD
Raltegravir—Dyspepsia—Citalopram—alcohol dependence	0.000156	0.000675	CcSEcCtD
Raltegravir—Decreased appetite—Citalopram—alcohol dependence	0.000155	0.000667	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000153	0.000662	CcSEcCtD
Raltegravir—Fatigue—Citalopram—alcohol dependence	0.000153	0.000661	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADH1A—alcohol dependence	0.000153	0.00118	CbGpPWpGaD
Raltegravir—Constipation—Citalopram—alcohol dependence	0.000152	0.000656	CcSEcCtD
Raltegravir—Pain—Citalopram—alcohol dependence	0.000152	0.000656	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR2A—alcohol dependence	0.000147	0.00113	CbGpPWpGaD
Raltegravir—Feeling abnormal—Citalopram—alcohol dependence	0.000146	0.000632	CcSEcCtD
Raltegravir—Gastrointestinal pain—Citalopram—alcohol dependence	0.000145	0.000627	CcSEcCtD
Raltegravir—Urticaria—Citalopram—alcohol dependence	0.000141	0.000609	CcSEcCtD
Raltegravir—Abdominal pain—Citalopram—alcohol dependence	0.000141	0.000606	CcSEcCtD
Raltegravir—Body temperature increased—Citalopram—alcohol dependence	0.000141	0.000606	CcSEcCtD
Raltegravir—Hypersensitivity—Citalopram—alcohol dependence	0.000131	0.000565	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADH4—alcohol dependence	0.00013	0.001	CbGpPWpGaD
Raltegravir—Asthenia—Citalopram—alcohol dependence	0.000128	0.00055	CcSEcCtD
Raltegravir—Pruritus—Citalopram—alcohol dependence	0.000126	0.000543	CcSEcCtD
Raltegravir—Diarrhoea—Citalopram—alcohol dependence	0.000122	0.000525	CcSEcCtD
Raltegravir—Dizziness—Citalopram—alcohol dependence	0.000118	0.000507	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—POMC—alcohol dependence	0.000117	0.000904	CbGpPWpGaD
Raltegravir—Vomiting—Citalopram—alcohol dependence	0.000113	0.000488	CcSEcCtD
Raltegravir—Rash—Citalopram—alcohol dependence	0.000112	0.000484	CcSEcCtD
Raltegravir—Dermatitis—Citalopram—alcohol dependence	0.000112	0.000483	CcSEcCtD
Raltegravir—Headache—Citalopram—alcohol dependence	0.000111	0.000481	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADH7—alcohol dependence	0.000111	0.000852	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT2—alcohol dependence	0.000106	0.000817	CbGpPWpGaD
Raltegravir—Nausea—Citalopram—alcohol dependence	0.000106	0.000456	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ADH1B—alcohol dependence	9.69e-05	0.000747	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MAOB—alcohol dependence	8.03e-05	0.000619	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EP300—alcohol dependence	7.78e-05	0.0006	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDH2—alcohol dependence	6.83e-05	0.000526	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—alcohol dependence	5.81e-05	0.000448	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2E1—alcohol dependence	5.46e-05	0.000421	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—alcohol dependence	5.01e-05	0.000386	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—alcohol dependence	5.01e-05	0.000386	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MAOA—alcohol dependence	4.49e-05	0.000346	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—alcohol dependence	2.92e-05	0.000225	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—EP300—alcohol dependence	1.94e-05	0.00015	CbGpPWpGaD
